Shares of Blueprint Medicines Co. (NASDAQ:BPMC – Get Rating) fell 5.9% during mid-day trading on Thursday following insider selling activity. The company traded as low as $56.44 and last traded at $56.48. 317,027 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 581,232 shares. The stock had previously […]
Stock prices of multiple cancer drug companies soared Monday following the release of positive clinical trial results for their therapies at an ongoing industry conference in Chicago.
Blueprint Medicines (NASDAQ:BPMC – Get Rating) and Hypera (OTCMKTS:HYPMY – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Analyst Recommendations This is a summary of current recommendations and price […]
Tuesday's top analyst upgrades and downgrades included Aflac, Cloudflare, Comerica, Comstock Resources, Costco Wholesale, Dollar General, Dominion Energy, Equitrans Midstream, Ford, Meta Platforms, T-Mobile, Valley National Bancorp and Walmart.
Form N-CSRS Destra Investment Trust For: Mar 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.